Bachelor of Science in Nursing
Diversity and Inclusion
End of Life Option Act
Mission, Vision & Values
Quality & Awards
Lung cancer is the leading cause of cancer deaths in this country. At the Sequoia Hospital Lung Cancer program, we offer Bay Area lung cancer patients a comprehensive approach to treatment that includes a focus on early detection.
In a unique collaboration with doctors from the University of California, San Francisco (UCSF) Medical Center, Sequoia’s Lung Cancer Program offers:
Sequoia’s Lung Cancer Early Detection program is a participating member of the International Early Lung Cancer Action Program (I-ELCAP). We are one of only 50 institutions worldwide participating in I-ELCAP, the first research study of its kind evaluating the effectiveness of screening for lung cancer with low-dose CT scanning.
I-ELCAP is designed specifically for lung cancer screening in:
Patients who do not qualify for I-ELCAP, or do not want to participate in the trial, will be referred to lung cancer specialists for a consultation.
This clinical pathway reflects Sequoia’s unique, comprehensive approach to lung cancer diagnosis and treatment. It is overseen by a program coordinator who also provides individual patient education and support.